Registered Zambia · ZAMRA

Antisedan 10ml injection

Atipamezole hydrochloride

327/721V Solution for Injection INN generic

What it does

Atipamezole is used to reverse sedation caused by certain medications in animals.

Commonly used for: reversal of sedation in animals

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
327/721V
Registration date
2026-06-25
Expiry date
2031-06-24
Status
Registered/Compliant
Active ingredient
Atipamezole hydrochloride
Strength
-
Pack size
-
Therapeutic class
-
RxNorm RxCUI
18475
Manufacturer / MAH
Zoetis
Applicant / LTR
ZOETIS BELGIUM SA
Country of origin
Belgium
Manufacturer location
Mercuriusstraat 20, 1930 Zaventem, Belgium

Source: Zambia Medicines Regulatory Authority · fetched 2026-06-28 06:27:54 · updated 2026-10-19 03:40:28

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Atipamezole is used to reverse sedation caused by certain medications in animals.

What it treats

  • reversal of sedation in animals

How it works

Atipamezole works by blocking the effects of sedative drugs, helping the animal to wake up more quickly.

Who it's for

This medication is for use in animals that have been sedated.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: atipamezole

BNF-referenced

Atipamezole is a selective alpha-2 adrenergic antagonist primarily used as a reversal agent for sedation induced by alpha-2 agonists in veterinary medicine. It acts by competitively inhibiting the alpha-2 adrenergic receptors, leading to a rapid reversal of sedation and analgesia caused by drugs such as medetomidine and dexmedetomidine. Its chemical structure is represented by the molecular formula C14H16N2.

Indications

  • Reversal of sedation induced by alpha-2 agonists in veterinary medicine
  • Management of sedation in animals

Dosage

Children: Refer to the BNF for Children for dosing information in paediatric patients.

Adults: Refer to the specific product label and veterinary guidelines for dosing information, as this can vary based on the specific alpha-2 agonist used and the condition being treated.

Mechanism of action

Atipamezole acts as an antagonist at central and peripheral alpha-2 adrenergic receptors. By blocking these receptors, it counteracts the effects of sedative agents, leading to increased release of norepinephrine and enhancement of sympathetic outflow, which results in arousal and normalization of cardiovascular parameters.

Pharmacodynamics

Atipamezole's pharmacodynamic effects include rapid reversal of sedation, restoration of normal physiological functions, and improvement of cardiovascular stability. It exhibits a high degree of selectivity for alpha-2 adrenergic receptors, which contributes to its efficacy in reversing sedation without causing significant stimulant effects.

Pharmacokinetics

Atipamezole is rapidly absorbed following parenteral administration. It has a relatively short half-life, allowing for quick recovery from sedation. The drug undergoes hepatic metabolism, and its metabolites are primarily excreted via the urine. The pharmacokinetic profile may vary based on the specific species and individual patient factors.

Adverse effects

  • Sedation
  • Tachycardia
  • Hypotension
  • Vomiting
  • Diarrhea

Precautions

  • Use with caution in animals with a history of cardiovascular disease.
  • Monitor heart rate and blood pressure during administration.

Pregnancy

Safety in pregnancy has not been established.

Breast-feeding

Safety during lactation has not been established.

Storage

Store at room temperature, away from light and moisture.

Formulations

  • Injectable solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: atipamezole

PubChem CID 71310

Molecular formula: C14H16N2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.